Why Medtronic Is One of the Smartest Companies on the Planet
Leo Sun, The Motley Fool - Motley Fool - Sat Apr 19, 9:00AM CDT
MIT Tech Review recently named Medtronic one of of the 50 smartest companies of 2013, placing the 65-year-old medical device company side by side with much younger companies like Google , and...
Heart Device Lawsuits Continue Against St. Jude Medical, Inc. Over Defective Riata Lead Wires says The Torkzadeh Law Firm
PR Newswire - Fri Apr 18, 12:44PM CDT
The Torkzadeh Law Firm (TorkLaw) is now representing over 100 clients against St. Jude Medical, Inc. related to the recalled St. Jude Medical, Inc. Riata leads.
Earnings Roundup: St. Jude's 1 Bright Spot
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 17, 5:30PM CDT
St. Jude 's tepid first-quarter results mask a quickening in sales for the company's atrial fibrillation products that shouldn't be ignored by investors. St. Jude has been boosting its atrial fibrillation, or AF, offering in anticipation of...
Baxter Tops Earnings & Revenues Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 12:10PM CDT
BAX also reiterated its outlook for full year 2014.
Company News for April 17, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 9:06AM CDT
Companies in the News are: BAC,IBKR,STJ,ABT
Injunction Lifted on Boston Scientific's Guidezilla - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 5:50PM CDT
Boston Scientific's Guidezilla guide extension catheter gets freed of an injunction by the U.S. Court of Appeals for the Federal Circuit.
St. Jude falls on soft earnings
at Investor's Business Daily - Wed Apr 16, 5:48PM CDT
Device maker St. Jude Medical (STJ) posted Q1 earnings and guidance that modestly beat Wall Street's expectations Wed., but investors were unimpressed as its stock was down nearly 2% to 62.04. EPS climbed 4% to 96 cents due to lower taxes, analysts...
St. Jude Medical Inc.: In-Line Is Just Not Good Enough
Stephen D., Simpson,, The Motley Fool - Motley Fool - Wed Apr 16, 5:30PM CDT
It's hard to call it a bad thing when Wall Street likes a stock, but rising expectations can create problems of their own. St. Jude Medical seems to have done a good job of selling the Street on the idea that it has turned over a new leaf and that...
After Yesterday's Decline of 1.88%, St Jude Medical Offers Investors Better Value
Comtex SmarTrend(R) - Wed Apr 16, 4:51PM CDT
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $59.85 to a high of $63.45. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $61.47 on volume of 5.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
St Jude Medical Falls 1.88% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Apr 16, 4:50PM CDT
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $59.85 to a high of $63.45. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $61.47 on volume of 5.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FDA Clears Boston Scientific's Heart Devices - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 2:10PM CDT
Boston Scientific won the U.S. FDA approval for a bunch of defibrillators and heart failure devices.
FDA Nod for Covidien's Kangaroo Feeding Tube - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 2:00PM CDT
Shares of Covidien rose 1.3% since the announcement to close at $69.90 yesterday.
St. Jude Medical (STJ) Stock Down Despite Positive Earnings Report
at The Street - Wed Apr 16, 10:42AM CDT
St. Jude Medical (STJ) tumbles in trading despite beating analysts EPS estimates by 1 cent
St. Jude Medical Earnings In Line, But Stock Falls
at Investor's Business Daily - Wed Apr 16, 10:31AM CDT
Device maker St. Jude Medical (STJ) met Wall Street's expectations with its Q1 results and guidance Wednesday, but the stock was down 3% in morning trading on the stock market today. St. Jude's sales rose 2% over the year-earlier quarter to $1.36...
St. Jude Beats Earnings by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 9:24AM CDT
For full year 2014, St. Jude Medical upgraded its revenues guidance to the range of $5,610 to $5,760 million from the prior range of $5,600 million to $5,750 million.
St Jude Medical (STJ) Falls Further As It's Water-Logged And Getting Wetter
at The Street - Wed Apr 16, 9:11AM CDT
Trade-Ideas LLC identified St Jude Medical (STJ) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
St. Jude Medical Reports First Quarter 2014 Results
Business Wire - Wed Apr 16, 6:30AM CDT
St. Jude Medical, Inc. (NYSE:STJ) today reported sales and net earnings for the first quarter ended March 29, 2014.
Will St. Jude Medical (STJ) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 3:32PM CDT
Our proven model does not conclusively show that St. Jude Medical is likely to beat earnings this quarter.
Johnson & Johnson's Earnings Report Impresses
Stephen D., Simpson,, The Motley Fool - Motley Fool - Tue Apr 15, 3:28PM CDT
If you're going to have a "messy" quarter, you probably couldn't do it much better than Johnson & Johnson did in the first quarter. Devices and Consumer continue to log disappointing results, but the higher-margin Pharma...
The New Wave in Covidien's Endoscopic Devices - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 2:00PM CDT
Shares of Covidien rose 1.3% in the trading session following the news release and closed at $69.92 yesterday.